BBIO
Price
$66.75
Change
+$0.14 (+0.21%)
Updated
Sep 29, 01:03 PM (EDT)
Capitalization
12.82B
30 days until earnings call
Intraday BUY SELL Signals
BBP
Price
$105.32
Change
+$0.30 (+0.29%)
Updated
Sep 29, 11:54 AM (EDT)
Net Assets
130.83M
Intraday BUY SELL Signals
Interact to see
Advertisement

BBIO vs BBP

BBIO vs BBP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BBIO vs. BBP commentary
Sep 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a StrongBuy and BBP is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BBIO: Fundamental Ratings
BBIO
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOBBP
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 7 days ago
75%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 19 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 29, 2026
Stock price -- (BBIO: $66.61)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green while .

  • BBIO’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 3 TA indicator(s) are bullish.

  • BBIO’s TA Score: 3 bullish, 5 bearish.

Price Growth

BBIO (@Biotechnology) experienced а +0.05% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.02%. For the same industry, the average monthly price growth was -7.91%, and the average quarterly price growth was +3.12%.

Reported Earning Dates

BBIO is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-0.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BBIO
Daily Signal:
Gain/Loss:
BBP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RZLT4.180.28
+7.18%
Rezolute
DMAAU10.82N/A
N/A
Drugs Made In America Acquisition Corp
UA4.24-0.13
-2.97%
Under Armour
CRGO1.01-0.03
-3.33%
Freightos Limited
AYI305.91-13.51
-4.23%
Acuity Inc

BBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBP has been loosely correlated with GERN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BBP jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBP
1D Price
Change %
BBP100%
+0.34%
GERN - BBP
55%
Loosely correlated
-0.79%
IOVA - BBP
51%
Loosely correlated
-0.09%
CYTK - BBP
51%
Loosely correlated
+2.32%
BBIO - BBP
49%
Loosely correlated
+1.59%
ONC - BBP
45%
Loosely correlated
+1.70%
More